Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 6.70
-0.18 (-2.62%)
May 11, 2026, 3:30 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 555.52 million as of May 11, 2026. Its market cap has decreased by -36.79% in one year.
Market Cap
555.52M
Enterprise Value
4.39B
Revenue
883.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.70
Market Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 555.52M, a decrease of -46.59%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 555.52M | -62.08% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.98B |
| Sigachi Industries | 8.38B |
| Valiant Laboratories | 4.30B |
| Bafna Pharmaceuticals | 3.12B |
| Nectar Lifesciences | 2.79B |
| Balaxi Pharmaceuticals | 1.57B |
| Alpa Laboratories | 1.48B |
| Brooks Laboratories | 1.47B |